Both in Surgical Instruments
ResMed vs Boston Scientific
Over the past year RMD returned −2.4% and BSX returned −53.6%; their daily moves had a correlation of 0.24.
RMD −2.4% BSX −53.6%Growth of $1, one year, split-adjusted
| Metric | RMD | BSX |
|---|---|---|
| Price | $240.51 | $45.82 |
| Market cap | $33.83B | $66.40B |
| Today | +5.91% | +5.33% |
| 1 month | +9.0% | +8.6% |
| 6 months | +14.7% | −18.2% |
| Year to date | −0.1% | −51.9% |
| 1 year | −3.4% | −53.5% |
| Revenue growth (YoY) | +5.9% | +1.4% |
| Gross margin | 61.5% | 66.7% |
| Net margin | 29.6% | 11.3% |
| P/E (TTM) | 21.2× | 19.0× |
| Price / sales | 5.9× | 3.2× |
| Net cash | $601.1M | -$11.34B |
| Dividend yield | 1.10% | — |
| Volatility (60d) | 32.6% | 37.9% |
| Short % of float | 8.5% | 2.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).